Читать «Трещина в мироздании» онлайн - страница 193

137

C. Whitelaw et al., “Genetically Engineering Milk”, Journal of Dairy Research 83 (2016): 3–11.

138

D. J. Holtkamp et al., “Assessment of the Economic Impact of Porcine Reproductive and Respiratory Syndrome Virus on United States Pork Producers”, Journal of Swine Health and Production 21 (2013): 72–84.

139

K. M. Whitworth et al., “Use of the CRISPR/Cas9 System to Produce Genetically Engineered Pigs from In Vitro-Derived Oocytes and Embryos”, Biology of Reproduction 91 (2014): 1–13.

140

K. M. Whitworth et al., “Gene-Edited Pigs Are Protected from Porcine Reproductive and Respiratory Syndrome Virus”, Nature Biotechnology 34 (2016): 20–22.

141

Center for Food Security and Public Health, “African Swine Fever”, www.cfsph.iastate.edu/Factsheets/pdfs/african_swine_fever.pdf.

142

C. J. Palgrave et al., “Species-Specific Variation in RELA Underlies Differences in NF-κB Activity: A Potential Role in African Swine Fever Pathogenesis”, Journal of Virology 85 (2011): 6008–6014.

143

S. G. Lillico et al., “Mammalian Interspecies Substitution of Immune Modulatory Alleles by Genome Editing”, Scientific Reports 6 (2016): 21645.

144

H. Devlin, “Could These Piglets Become Britain’s First Commercially Viable GM Animals?”, Guardian, June 23, 2015.

145

B. Graf and M. Senn, “Behavioural and Physiological Responses of Calves to Dehorning by Heat Cauterization with or Without Local Anaesthesia”, Applied Animal Behaviour Science 62 (1999): 153–171.

146

I. Medugorac et al., “Bovine Polledness – an Autosomal Dominant Trait with Allelic Heterogeneity”, PLoS ONE 7 (2012): e39477.

147

D. F. Carlson et al., “Production of Hornless Dairy Cattle from Genome-Edited Cell Lines”, Nature Biotechnology 34 (2016): 479–481.

148

K. Grens, “GM Calves Move to University”, Scientist, December 21, 2015.

149

N. Rosenthal and Steve Brown, “The Mouse Ascending: Perspectives for Human-Disease Models”, Nature Cell Biology 9 (2007): 993–999; www.findmice.org/repository.

150

B. Shen et al., “Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos”, Cell 156 (2014): 836–843.

151

H. Wan et al., “One-Step Generation of p53 Gene Biallelic Mutant Cynomolgus Monkey via the CRISPR/Cas System”, Cell Research 25 (2015): 258–261.

152

Y. Chen et al., “Functional Disruption of the Dystrophin Gene in Rhesus Monkey Using CRISPR/Cas9”, Human Molecular Genetics 24 (2015): 3764–3774.

153

Z. Tu et al., “CRISPR/Cas9: A Powerful Genetic Engineering Tool for Establishing Large Animal Models of Neurodegenerative Diseases”, Molecular Neurodegeneration 10 (2015): 35–42; Z. Liu et al., “Generation of a Monkey with MECP2 Mutations by TALEN-Based Gene Targeting”, Neuroscience Bulletin 30 (2014): 381–386.

154

C. Sheridan, “FDA Approves ‘Farmaceutical’ Drug from Transgenic Chickens”, Nature Biotechnology 34 (2016): 117–119.

155

L. R. Bertolini et al., “The Transgenic Animal Platform for Biopharmaceutical Production”, Transgenic Research 25 (2016): 329–343.